about
Antibiotics in the clinical pipeline at the end of 2015.The potential role of nemonoxacin for treatment of common infections.Managing community acquired pneumonia in the elderly - the next generation of pharmacotherapy on the horizon.In Vitro Resistance Development to Nemonoxacin in Streptococcus pneumoniae: A Unique Profile for a Novel Nonfluorinated Quinolone.Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer Activities.
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Nemonoxacin: first global approval.
@en
type
label
Nemonoxacin: first global approval.
@en
prefLabel
Nemonoxacin: first global approval.
@en
P2860
P1433
P1476
Nemonoxacin: first global approval.
@en
P2093
Raewyn M Poole
P2860
P2888
P304
P356
10.1007/S40265-014-0270-0
P577
2014-08-01T00:00:00Z
P6179
1023088995